Spirometry<\/strong>: estimates the volume of air that a person can inhale and exhale.<\/p>\n<\/li>\n Bronchodilator tests<\/strong>: help determine the reversibility of obstruction.<\/p>\n<\/li>\n Provocative tests<\/strong> (e.g., with methacholine): confirm bronchial hyperreactivity.<\/p>\n<\/li>\n Nitric oxide (FeNO) measurement<\/strong>: marker of eosinophilic inflammation.<\/p>\n<\/li>\n Allergy tests and IgE analyses<\/strong>: allow to identify the atopic nature of the disease.<\/p>\n<\/li>\n<\/ul>\n Patients become accustomed to symptoms. For example, a persistent morning cough or shortness of breath when climbing stairs are perceived as \u00abnormal.\u00bb Such adaptation is dangerous because complications can appear suddenly \u2014 from asthmatic status to respiratory failure.<\/p>\n Modern therapy for bronchial asthma is based on a stepwise approach, according to the international GINA strategy. Treatment should be dynamic - depending on how well the disease is controlled.<\/p>\n The most common mistake is to stop treatment on your own after symptoms disappear. Asthma requires long-term control, even during remission.<\/p>\n Chronic inflammation can lead to airway remodeling, which is irreversible changes in the airways. This means that treatment is less effective in the future. In addition, patients with uncontrolled asthma are more likely to have infections, have problems with sleep, concentration, and work capacity.<\/p>\n Effective treatment depends not only on medications, but also on the patient's level of awareness. Learning proper inhalation technique, recognizing triggers, and keeping a symptom diary all significantly reduce the risk of exacerbations.<\/p>\n A 15-year-old boy who had been hospitalized repeatedly with pneumonia was finally diagnosed with asthma only after FeNO testing and spirometry. After starting basic therapy, the frequency of exacerbations decreased from 5 times a year to 1.<\/p>\n Asthma is a chronic but controllable disease. And the earlier the correct diagnosis is made, the better the chances of an active life without attacks and hospitalizations.<\/p>","protected":false},"excerpt":{"rendered":" Individual manifestations of asthma: there is no one-size-fits-all scenario. Bronchial asthma affects people regardless of age, but the course may be different for everyone.<\/p>","protected":false},"author":627,"featured_media":9723,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9722","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/posts\/9722","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/users\/627"}],"replies":[{"embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/comments?post=9722"}],"version-history":[{"count":0,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/posts\/9722\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/media\/9723"}],"wp:attachment":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/media?parent=9722"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/categories?post=9722"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/tags?post=9722"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Why symptoms are often ignored: the adaptation trap<\/h2>\n
Treatment variability: there is no universal inhaler<\/h2>\n
\n\n
\n \nTherapy step<\/th>\n Appointment<\/th>\n Example of drugs<\/th>\n<\/tr>\n<\/thead>\n \n Initial<\/td>\n Treatment on demand<\/td>\n Inhalers with a combination of ICS + LABA<\/td>\n<\/tr>\n \n Control<\/td>\n Regular daily treatment<\/td>\n Budesonide, Seretide, Symbicort<\/td>\n<\/tr>\n \n Reinforced<\/td>\n For severe persistent form<\/td>\n Biologics (omalizumab)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Uncontrolled complications: not just the lungs<\/h2>\n
![\"Portable](\"https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/05\/000-1.jpg\")
<\/p>\nEducational component: the key to success<\/h2>\n
Practical example<\/h2>\n